日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Geography-independent mucosal microbiota alterations in primary sclerosing cholangitis persist after liver transplantation

原发性硬化性胆管炎中与地理位置无关的黏膜微生物群改变在肝移植后仍然存在

Bajer, Lukas; Polakovicova, Petra; Heczkova, Marie; Holm, Kristian; Hole, Mikal J; Hlavaty, Mojmir; Bohdanecka, Alena; Drastich, Pavel; Tichanek, Filip; Meyer-Myklestad, Malin H; Medhus, Asle W; Reikvam, Dag Henrik; Jørgensen, Kristin K; Brezina, Jan; Macinga, Peter; Wohl, Pavel; Fabian, Ondrej; Hov, Johannes R; Cahova, Monika

Identifying biomarkers for diagnosis and disease activity monitoring in PSC-IBD and UC through proteomic profiling: A prospective, biomarker discovery single-center study protocol

通过蛋白质组学分析鉴定PSC-IBD和UC的诊断和疾病活动监测生物标志物:一项前瞻性、生物标志物发现的单中心研究方案

Fabian, Ondrej; Bajer, Lukas; Macinga, Peter; Brezina, Jan; Hlavaty, Mojmir; Drastich, Pavel; Wohl, Pavel; Harant, Karel; Talacko, Pavel; Sticova, Eva; Vajsova, Andrea; Bohdanecka, Alena; Tichanek, Filip; Cahova, Monika

Persistence of advanced therapies in patients with ulcerative colitis: real-world data from the nationwide CREdIT registry

溃疡性结肠炎患者持续接受先进疗法:来自全国性 CRedIT 注册研究的真实世界数据

Hradsky, Ondrej; Duricova, Dana; Lukas, Milan; Nedbalová, Lenka; Pipek, Barbora; Drastich, Pavel; Falt, Premysl; Vanasek, Tomas; Svikova, Jana; Siroky, Milan; Bouchner, Ludek; Svoboda, Pavel; Bronsky, Jiri; Bortlik, Martin

Long-term Results of Duodeno-jejunal Bypass in the Treatment of Obesity and Type 2 Diabetes

十二指肠空肠旁路术治疗肥胖症和2型糖尿病的长期疗效

Kral, Jan; Benes, Marek; Lanska, Vera; Macinga, Peter; Drastich, Pavel; Spicak, Julius; Hucl, Tomas

Novel upper gastrointestinal bleeding sensor capsule: a first human feasibility and safety trial

新型上消化道出血传感器胶囊:首次人体可行性和安全性试验

Bajer, Lukas; Ryou, Marvin; C Thompson, Christopher; Drastich, Pavel

Limited validity of Mayo endoscopic subscore in ulcerative colitis with concomitant primary sclerosing cholangitis

Mayo内镜评分在伴有原发性硬化性胆管炎的溃疡性结肠炎中的有效性有限

Wohl, Pavel; Krausova, Alzbeta; Wohl, Petr; Fabian, Ondrej; Bajer, Lukas; Brezina, Jan; Drastich, Pavel; Hlavaty, Mojmir; Novotna, Petra; Kahle, Michal; Spicak, Julius; Gregor, Martin

A Current State of Proteomics in Adult and Pediatric Inflammatory Bowel Diseases: A Systematic Search and Review

成人和儿童炎症性肠病蛋白质组学研究现状:系统性检索与综述

Fabian, Ondrej; Bajer, Lukas; Drastich, Pavel; Harant, Karel; Sticova, Eva; Daskova, Nikola; Modos, Istvan; Tichanek, Filip; Cahova, Monika

Serum TGF- β 1 and CD14 Predicts Response to Anti-TNF- α Therapy in IBD

血清 TGF- β 1 和 CD14 可预测 IBD 对抗 TNF- α 治疗的反应

Stepan Coufal, Miloslav Kverka, Jakub Kreisinger, Tomas Thon, Filip Rob, Martin Kolar, Zuzana Reiss, Dagmar Schierova, Klara Kostovcikova, Radka Roubalova, Lukas Bajer, Zuzana Jackova, Martin Mihula, Pavel Drastich, Jana Tresnak Hercogova, Michaela Novakova, Martin Vasatko, Milan Lukas, Helena Tlask

Association between ustekinumab therapy and changes in specific anti-microbial response, serum biomarkers, and microbiota composition in patients with IBD: A pilot study

乌司奴单抗治疗与炎症性肠病患者特异性抗菌反应、血清生物标志物和微生物群组成变化之间的关联:一项初步研究

Rob, Filip; Schierova, Dagmar; Stehlikova, Zuzana; Kreisinger, Jakub; Roubalova, Radka; Coufal, Stepan; Mihula, Martin; Jackova, Zuzana; Kverka, Miloslav; Thon, Tomas; Kostovcikova, Klara; Bajer, Lukas; Drastich, Pavel; Hercogova, Jana Tresnak; Novakova, Michaela; Kolar, Martin; Vasatko, Martin; Lukas, Milan; Tlaskalova-Hogenova, Helena; Jiraskova Zakostelska, Zuzana

Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy.

抗TNF治疗期间IBD患者的粪便微生物组变化和特异性抗菌反应

Schierova Dagmar, Roubalova Radka, Kolar Martin, Stehlikova Zuzana, Rob Filip, Jackova Zuzana, Coufal Stepan, Thon Tomas, Mihula Martin, Modrak Martin, Kverka Miloslav, Bajer Lukas, Kostovcikova Klara, Drastich Pavel, Hercogova Jana, Novakova Michaela, Vasatko Martin, Lukas Milan, Tlaskalova-Hogenova Helena, Jiraskova Zakostelska Zuzana